BMAL1 and head and neck squamous cell carcinoma: Studies on glioma [47], head and neck squamous cell carcinoma [48], lung [49], colorectal [50] and liver cancers [51] demonstrated that PERs, CRYs and BMAL1 are downregulated in tumours and are likely to harbour tumour suppressing qualities.